Sudhir Singh Sanwal

Title: Sudhir Singh Sanwal: Innovator in Pharmaceutical Chemistry

Introduction

Sudhir Singh Sanwal is a notable inventor based in Kangra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug formulation. With a total of 2 patents to his name, Sanwal's work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Sanwal's latest patents include a process for the preparation of crystalline Form I of methanesulfonate salt of dabigatran etexilate. This invention relates to a method that does not require the isolation of the dabigatran etexilate intermediate, streamlining the production process. Another significant patent is for the preparation of stable crystalline Form II of L-malic acid salt of sunitinib, which enhances the stability and efficacy of this important pharmaceutical compound.

Career Highlights

Sanwal is currently associated with Ranbaxy Laboratories, Inc., where he applies his expertise in pharmaceutical development. His work at Ranbaxy has allowed him to focus on innovative drug formulations that can lead to improved therapeutic outcomes.

Collaborations

Sanwal has collaborated with several talented individuals in his field, including Swargam Sathyanarayana and Saridi Madhava Dileep Kumar. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Sudhir Singh Sanwal's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to pave the way for advancements in drug formulation and stability.